These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3856963

  • 1. Cytokinetic studies in acute leukemia during early induction therapy.
    Traversi E, Riccardi A, Montecucco C, Mazzini G, Giordano P.
    Tumori; 1985 Feb 28; 71(1):69-74. PubMed ID: 3856963
    [Abstract] [Full Text] [Related]

  • 2. Histomorphologic study of bone marrow in acute leukemia following chemotherapy and autologous bone marrow transplantation.
    Muretto P, Izzi T, Grianti C, Moretti L.
    Tumori; 1983 Jun 30; 69(3):239-48. PubMed ID: 6346621
    [Abstract] [Full Text] [Related]

  • 3. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
    Jahns-Streubel G, Reuter C, Unterhalt M, Schleyer E, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1995 Nov 30; 9(11):1857-63. PubMed ID: 7475275
    [Abstract] [Full Text] [Related]

  • 4. Prognotic significance of pretreatment proliferative activity in adult acute leukemia.
    Hart JS, George SL, Frei E, Bodey GP, Nickerson RC, Freireich EJ.
    Cancer; 1977 Apr 30; 39(4):1603-17. PubMed ID: 265746
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of acute nonlymphocytic leukemia induction chemotherapy in acute lymphocytic leukemia.
    Cassileth PA, Bennett JM.
    Cancer Treat Rep; 1985 Dec 30; 69(12):1439-40. PubMed ID: 3865702
    [Abstract] [Full Text] [Related]

  • 6. [Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
    Creutzig U, Ritter I, Schellong G.
    Gematol Transfuziol; 1991 Jan 30; 36(1):16-21. PubMed ID: 2065939
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of advanced bone marrow neoplasms with ifosfamide combinations.
    Norberg B, Holm J, Winqvist E, Wahlin A.
    Scand J Haematol; 1984 Jan 30; 32(1):95-100. PubMed ID: 6582586
    [Abstract] [Full Text] [Related]

  • 8. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
    Rees JK, Gray RG.
    Haematol Blood Transfus; 1990 Jan 30; 33():243-8. PubMed ID: 1691131
    [No Abstract] [Full Text] [Related]

  • 9. Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia.
    Amato R, Kantarjian H, Walters R, Keating M.
    Cancer; 1988 Feb 15; 61(4):650-3. PubMed ID: 3422175
    [Abstract] [Full Text] [Related]

  • 10. Intensive treatment of acute leukemia in adults 70 years of age and older.
    Walters RS, Kantarjian HM, Keating MJ, Estey EH, McCredie KB, Freireich EJ.
    Cancer; 1987 Jul 15; 60(2):149-55. PubMed ID: 3474052
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
    Zhonghua Nei Ke Za Zhi; 1992 Mar 15; 31(3):139-42, 187. PubMed ID: 1395923
    [Abstract] [Full Text] [Related]

  • 12. Serial quantitative observations of leukemic and normal hematopoietic cells in the bone marrow of acute leukemia under chemotherapy.
    Ohshima T, Amaki I.
    Tohoku J Exp Med; 1976 May 15; 119(1):27-40. PubMed ID: 1065964
    [Abstract] [Full Text] [Related]

  • 13. Adult acute leukaemia.
    Atkinson K, Wells DG, Clink HM, Kay HE, Powles R, McElwain TJ.
    Br J Cancer; 1974 Sep 15; 30(3):272-8. PubMed ID: 4141625
    [Abstract] [Full Text] [Related]

  • 14. Oscillations of marrow culture growth in acute myeloid leukemia during remission induction and remission.
    Gustavsson A, Olofsson T, Olsson I.
    Acta Haematol; 1979 Sep 15; 62(5-6):241-6. PubMed ID: 121664
    [Abstract] [Full Text] [Related]

  • 15. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M.
    Wiad Lek; 1995 Sep 15; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract] [Full Text] [Related]

  • 16. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
    Sanz MA, Lorenzo JI, Sanz GF, Martín Aragonés G, Rafecas FJ, Martínez JA, Gomis F.
    Sangre (Barc); 1988 Dec 15; 33(6):497-504. PubMed ID: 3247626
    [No Abstract] [Full Text] [Related]

  • 17. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA, Cuttner J, Holland JF.
    Semin Oncol; 1984 Sep 15; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo effects of deferoxamine in neonatal acute leukemia.
    Estrov Z, Tawa A, Wang XH, Dubé ID, Sulh H, Cohen A, Gelfand EW, Freedman MH.
    Blood; 1987 Mar 15; 69(3):757-61. PubMed ID: 3493042
    [Abstract] [Full Text] [Related]

  • 19. The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis.
    Creutzig U, Ritter J, Riehm H, Budde M, Schellong G.
    Haematol Blood Transfus; 1987 Mar 15; 30():71-5. PubMed ID: 3305225
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of 218 adult acute lymphoblastic leukemias.
    Fiere D, Extra JM, David B, Witz F, Vernand JP, Gastaut JA, Dauriac C, Pris J, Marty M.
    Semin Oncol; 1987 Jun 15; 14(2 Suppl 1):64-6. PubMed ID: 3296208
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.